254 related articles for article (PubMed ID: 23861929)
1. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.
Zhang H; Li L; Xu Y
PLoS One; 2013; 8(7):e68634. PubMed ID: 23861929
[TBL] [Abstract][Full Text] [Related]
2. Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.
Wang F; Zou YF; Sun GP; Su H; Huang F
Eur J Cancer Prev; 2011 Mar; 20(2):112-20. PubMed ID: 21191305
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.
Yang J; Xu DL; Lu Q; Han ZJ; Tao J; Lu P; Wang C; Di XK; Gu M
Asian J Androl; 2012 Jul; 14(4):560-5. PubMed ID: 22504876
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 1B1 gene polymorphisms as predictors of anticancer drug activity: studies with in vitro models.
Laroche-Clary A; Le Morvan V; Yamori T; Robert J
Mol Cancer Ther; 2010 Dec; 9(12):3315-21. PubMed ID: 20889730
[TBL] [Abstract][Full Text] [Related]
5. Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.
Cui L; Dillehay K; Chen W; Shen D; Dong Z; Li W
Mol Biol Rep; 2012 Jul; 39(7):7465-71. PubMed ID: 22327650
[TBL] [Abstract][Full Text] [Related]
6. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
7. Association of CYP1B1 L432V polymorphism with urinary cancer susceptibility: a meta-analysis.
Jiang W; Sun G; Xiong J; Xi X; Shi Z
Diagn Pathol; 2014 Jun; 9():113. PubMed ID: 24913727
[TBL] [Abstract][Full Text] [Related]
8. CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians.
Beuten J; Gelfond JA; Byrne JJ; Balic I; Crandall AC; Johnson-Pais TL; Thompson IM; Price DK; Leach RJ
Carcinogenesis; 2008 Sep; 29(9):1751-7. PubMed ID: 18544568
[TBL] [Abstract][Full Text] [Related]
9. Associations of CYP1 polymorphisms with risk of prostate cancer: an updated meta-analysis.
Zhu W; Liu H; Wang X; Lu J; Zhang H; Wang S; Yang W
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30765615
[No Abstract] [Full Text] [Related]
10. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
11. CYP1B1 Asn453Ser polymorphism and colorectal cancer risk: a meta-analysis.
Mei Q; Zhou D; Han J; Lu H; Tang B
Metabolism; 2012 Sep; 61(9):1321-9. PubMed ID: 22459615
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-methyltransferase and cytochrome P-450 1B1 polymorphisms and endometrial cancer risk: a meta-analysis.
Teng Y; He C; Zuo X; Li X
Int J Gynecol Cancer; 2013 Mar; 23(3):422-30. PubMed ID: 23370603
[TBL] [Abstract][Full Text] [Related]
13. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
[TBL] [Abstract][Full Text] [Related]
14. Current evidence on the relationship between CYP1B1 polymorphisms and lung cancer risk: a meta-analysis.
Xu W; Zhou Y; Hang X; Shen D
Mol Biol Rep; 2012 Mar; 39(3):2821-9. PubMed ID: 21674184
[TBL] [Abstract][Full Text] [Related]
15. Primary role of CYP1B1 in Indian juvenile-onset POAG patients.
Acharya M; Mookherjee S; Bhattacharjee A; Bandyopadhyay AK; Daulat Thakur SK; Bhaduri G; Sen A; Ray K
Mol Vis; 2006 Apr; 12():399-404. PubMed ID: 16688110
[TBL] [Abstract][Full Text] [Related]
16. The CYP1B1 Leu432Val polymorphism and risk of urinary system cancers.
Liu Y; Lin CS; Zhang AM; Song H; Fan CC
Tumour Biol; 2014 May; 35(5):4719-25. PubMed ID: 24453031
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 1B1 and catechol-O-methyltransferase genetic polymorphisms and breast cancer risk in Chinese women: results from the shanghai breast cancer study and a meta-analysis.
Wen W; Cai Q; Shu XO; Cheng JR; Parl F; Pierce L; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):329-35. PubMed ID: 15734954
[TBL] [Abstract][Full Text] [Related]
18. No association of genetic polymorphisms in CYP1B1 with primary open-angle glaucoma: a meta- and gene-based analysis.
Dong S; Yang J; Yu W; Kota P; Xia X; Xu H
Mol Vis; 2012; 18():786-96. PubMed ID: 22509109
[TBL] [Abstract][Full Text] [Related]
19. Association of variants in estrogen-related pathway genes with prostate cancer risk.
Holt SK; Kwon EM; Fu R; Kolb S; Feng Z; Ostrander EA; Stanford JL
Prostate; 2013 Jan; 73(1):1-10. PubMed ID: 22549291
[TBL] [Abstract][Full Text] [Related]
20. Association of CYP1B1 gene polymorphisms and the positive expression of estrogen alpha and estrogen beta with endometrial cancer risk.
Zhu ZY; Mu YQ; Fu XM; Li SM; Zhao FX
Eur J Gynaecol Oncol; 2011; 32(2):188-91. PubMed ID: 21614911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
